A program for the treatment of psychosis with cerebral arteriosclerosis, with special emphasis on the intravenous administration of histamine and nicotinic acid; a preliminary report of 29 cases.
D061605:Administration, Intravenous; D006632:Histamine / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis; D009525:Niacin; D009539:Nicotinic Acids; D011618:Psychotic Disorders
D009539:Nicotinic Acids; D009525:Niacin; D006632:Histamine
HISTAMINE/therapeutic use